Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Empagliflozin, a Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, in Healthy Japanese Subjects
Drug Metabolism and Pharmacokinetics - Japan
doi 10.2133/dmpk.dmpk-12-rg-082
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Japanese Society for the Study of Xenobiotics